John Gribben
An expert in hematology and the treatment of hematological malignancies.
Top 3 podcasts with John Gribben
Ranked by the Snipd community
Nov 17, 2023 • 16min
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL
John Gribben and Laurie Sehn discuss the use of antibody-drug conjugates (ADCs) in NHL. They explore challenges in comparing treatment options, modulation of target antigen, and FDA's changing requirements for drug approval. Recent updates in the use of ADCs, including decreased accelerated approvals and the importance of efficacy and safety, are also highlighted.
Mar 3, 2023 • 9min
The current status of CAR-T therapy in CLL and challenges in this space
Learn about the challenges of CAR-T therapy in CLL and the possibilities of combining it with ibrutinib. Discover the latest advances in CAR-T therapy for Richter's transformation and the slower development of CAR-T therapy in CLL compared to other diseases.
Nov 9, 2022 • 14min
iwNHL Session II: understanding and harnessing the immune microenvironment against lymphoma
Experts at iwNHL discuss the importance of understanding the immune microenvironment in NHL, strategies to engage the anti-tumor immune response, and enhancing the efficacy of immune therapies. They explore opportunities for intervention in lymphoma treatment, challenges of engineering complex CARs, and the impact of chemotherapy on the tumor microenvironment.
